-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...
More »SEARCH RESULT
One-third of rural job funds spent in March
-The Times of India KOLKATA: It may be the impact of the efforts put in by officials led by panchayat minister Subrata Mukherjee in the past few months, or a matter of outdoing the former Left Front government in terms of figures. But the fact is that the Mamata Banerjee government has spent a whopping Rs 982.86 crore in this March alone under the Mahatma Gandhi National Rural Employment Guarantee Act...
More »The trouble with junk food-Sunita Narain
-The Business Standard It is not in the interest of food companies to advertise what their products contain, but it is in our interest to know Junk food is junk by its very definition. But how bad is it and what is it that companies do not tell people about this food? This is what the Centre for Science and Environment (CSE) laboratory checked. The results were both predictable and alarming....
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »